PD-1, PD-L1 in BRCA1/2-mutated and non-mutated epithelial ovarian carcinomas (EOCs).

被引：0
|
作者：
Sachdev, Jasgit C.
Arguello, David
Abbott, Brian L.
Reddy, Sandeep K.
机构：
[1] Scottsdale Healthcare, Paradise Valley, AZ USA
[2] Caris Life Sci, Phoenix, AZ USA
[3] Caris Life Sci, Great Falls, MT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e17057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17057
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PD-1/PD-L1 expression in BRCA1/2 mutated ovarian cancers
    Penn, C. A.
    Lester, J.
    Bohrer, K.
    Moon, C.
    Yearley, J.
    Karlan, B. Y.
    Walsh, C.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 33 - 33
  • [2] Molecular profiling comparison of BRCA1/2-mutated and BRCA1/2 non-mutated triple-negative breast cancer (TNBC)
    Arguello, D.
    Abbott, B.
    Reddy, S.
    Gatalica, Z.
    Obeid, E.
    Goldstein, L.
    CANCER RESEARCH, 2016, 76
  • [3] Comparative study between patients with mutated BRCA1 2 breast and or ovarian cancer and non-mutated BRCA1 2
    Habak, N.
    Abdellah, M. Ait
    Chikouche, A.
    Griene, L.
    CLINICA CHIMICA ACTA, 2024, 558
  • [4] Secondary BRCA1/2 mutations are associated with platinum resistance in BRCA1/2-mutated ovarian carcinomas
    Norguist, B.
    Taniguchi, T.
    Wurz, K.
    Karlan, B.
    Villegas, E.
    Sakai, W.
    Swisher, E.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 594 - 594
  • [5] Tumor infiltrating and peritumoral T cells and expression of PD-L1 in BRCA1/2-mutated high grade serous ovarian cancers.
    Strickland, Kyle
    Howitt, Brooke E.
    Rodig, Scott J.
    Ritterhouse, Lauren
    D'Andrea, Alan D.
    Matulonis, Ursula
    Konstantinopoulos, Panagiotis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Secondary BRCA1/2 mutations are associated with platinum resistance in a large series of BRCA1/2-mutated ovarian carcinomas
    Norquist, B.
    Sakai, W.
    Wurz, K.
    Karlan, B.
    Taniguchi, T.
    Swisher, E.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S4 - S4
  • [7] GENOMICS OF BRCA1/2-MUTATED BREAST CANCERS
    Jonkers, J.
    CELLULAR ONCOLOGY, 2010, 32 (03) : 162 - 162
  • [8] Morphologic Correlations with Homologous Recombination Deficiency in BRCA1/2-Mutated and Non-BRCA-Mutated High-Grade Serous Carcinomas
    Chapagain, Udita
    Sun, Lulu
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1121 - S1122
  • [9] Responses to carboplatin in BRCA1/2-mutated breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2018, 19 (07): : E337 - E337
  • [10] PD-1 AND PD-L1 EXPRESSION IN OVARIAN CANCER
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Fiegl, H.
    Marth, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 64 - 64
12345